Work

Circulating Prostasin: An Independent Risk Marker in Idiopathic Pulmonary Fibrosis (IPF)

Year: 2024

Type: conference-abstract

DOI: 10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a2866

Authors: J.L. Todd, C. Page, P. Wu, J.A. Belperio, T.M. Maher, S.M. Palmer, T.B. Leonard, C. Hesslinger, M.L. Neely, T. Schlange, on behalf of the IPF-PRO Registry investigators

Institutions: Duke Medical Center, Duke Clinical Research Institute, Boehringer Ingelheim (United States), University of California, Los Angeles, University of Southern California, Boehringer Ingelheim (Germany)

Language: English

Topic: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4396516135

Cites:

Cited by:

Related to: 10